{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:23:32Z","timestamp":1792265012964,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejim.2019.03.014","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T03:26:38Z","timestamp":1553311598000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"special_numbering":"C","title":["Euglycemic diabetic ketoacidosis"],"prefix":"10.1016","volume":"63","author":[{"given":"Leonid","family":"Barski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Eshkoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Brandstaetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Jotkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejim.2019.03.014_bb0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1464-5491.2011.03246.x","article-title":"Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis","volume":"28","author":"Savage","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejim.2019.03.014_bb0010","series-title":"Diabetes Care","volume":"29","author":"American Diabetes Association","year":"2006"},{"key":"10.1016\/j.ejim.2019.03.014_bb0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"issue":"5866","key":"10.1016\/j.ejim.2019.03.014_bb0020","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/bmj.2.5866.578","article-title":"Euglycaemic diabetic ketoacidosis","volume":"2","author":"Munro","year":"1973","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.ejim.2019.03.014_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic diabetic ketoacidosis: a review","volume":"13","author":"Modi","year":"2017","journal-title":"Curr Diabetes Rev"},{"issue":"9","key":"10.1016\/j.ejim.2019.03.014_bb0030","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabet Care"},{"issue":"4","key":"10.1016\/j.ejim.2019.03.014_bb0035","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2337\/dc17-1721","article-title":"SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis: a south Australian clinical case series and Australian spontaneous adverse event notifications","volume":"41","author":"Meyer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2019.03.014_bb0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/pmj.79.934.454","article-title":"Diabetic ketoacidosis in pregnancy","volume":"79","author":"Kamalakannan","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2019.03.014_bb0045","article-title":"Euglycemic diabetic ketoacidosis in the ICU: 3 case reports and review of literature","author":"Lucero","year":"2018","journal-title":"Case Rep Crit Care"},{"issue":"4","key":"10.1016\/j.ejim.2019.03.014_bb0050","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4158\/EP161447.LT","article-title":"Diabetic ketoacidosis in patients with type 2 diabetes recently commenced on SGLT-2 inhibitors: an ongoing concern","volume":"23","author":"Ahmed","year":"2017","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.ejim.2019.03.014_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jdi.12401","article-title":"Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors","volume":"7","author":"Ogawa","year":"2016","journal-title":"J Diabetes investing"},{"key":"10.1016\/j.ejim.2019.03.014_bb0060","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ejim.2019.03.014_bb0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrendo.2016.15","article-title":"Diabetic emergencies \u2014 ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia","volume":"12","author":"Umpierrez","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10.1016\/j.ejim.2019.03.014_bb0070","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2019.03.014_bb0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ogc.2007.08.001","article-title":"Diabetic ketoacidosis in pregnancy","volume":"34","author":"Parker","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ejim.2019.03.014_bb0080","series-title":"Diabetes in women: Adolescence, pregnancy, and menopause","author":"Reece","year":"2004"},{"key":"10.1016\/j.ejim.2019.03.014_bb0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1447-0756.2008.00720.x","article-title":"Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case\u2013control study and a case report of euglycemic diabetic ketoacidosis in pregnancy","volume":"34","author":"Guo","year":"2008","journal-title":"J Obstetr Gynaecol Res"},{"key":"10.1016\/j.ejim.2019.03.014_bb0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-2007-994386","article-title":"The changing presentations of diabetic ketoacidosis during pregnancy","volume":"13","author":"Cullen","year":"1996","journal-title":"Am J Perinatol"},{"issue":"17","key":"10.1016\/j.ejim.2019.03.014_bb0095","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3109\/14767058.2015.1107903","article-title":"Ketoacidosis in diabetic pregnancy","volume":"29","author":"Dalfr'a","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"10.1016\/j.ejim.2019.03.014_bb0100","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.clinthera.2016.11.002","article-title":"SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis","volume":"38","author":"Goldenberg","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.ejim.2019.03.014_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S2213-8587(15)00204-1","article-title":"SGLT inhibition and euglycaemic diabetic ketoacidosis","volume":"3","author":"Hine","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejim.2019.03.014_bb0110","article-title":"Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: basic mechanisms and therapeutic perspectives","volume":"33","author":"Oiu","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ejim.2019.03.014_bb0115","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/dc15-1251","article-title":"Diabetic ketoacidosis and related events in the Canagliflozin type 2 diabetes clinical program","volume":"38","author":"Erondu","year":"2015","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ejim.2019.03.014_bb0120","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic Diabetic Ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2019.03.014_bb0125","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/dom.12494","article-title":"Empagliflozin as adjunct to insulin in patients with type 1diabetes: a4-week, randomized, placebo-controlled trial (EASE-1)","volume":"17","author":"Pieber","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejim.2019.03.014_bb0130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/dom.12149","article-title":"Efficacy and safety of canagli- flozin in Japanese patients with type 2 diabetes: a randomized, double- blind, placebo-controlled, 12-week study","volume":"15","author":"Inagaki","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejim.2019.03.014_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1475-2840-13-65","volume":"13","author":"Kaku","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejim.2019.03.014_bb0140","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT 2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ejim.2019.03.014_bb0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2019.03.014_bb0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Merovci","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2019.03.014_bb0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/jdi.12330","article-title":"Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet","volume":"6","author":"Hayami","year":"2015","journal-title":"J Diabetes Investig"},{"issue":"1","key":"10.1016\/j.ejim.2019.03.014_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11606-008-0829-0","article-title":"Starvation-induced true diabetic euglycemic ketoacidosis in severe depression","volume":"24","author":"Joseph","year":"2009","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ejim.2019.03.014_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/meta.2001.20194","article-title":"Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis","volume":"50","author":"Burge","year":"2001","journal-title":"Metabolism."},{"key":"10.1016\/j.ejim.2019.03.014_bb0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198307213090307","article-title":"The metabolic derangements and treatment of diabetic ketoacidosis","volume":"309","author":"Foster","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2019.03.014_bb0175","first-page":"1192","article-title":"Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency","volume":"76","author":"Burge","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2019.03.014_bb0180","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1126\/science.1948033","article-title":"Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR","volume":"254","author":"Rothman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ejim.2019.03.014_bb0185","first-page":"E189","article-title":"Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects","volume":"252","author":"Wolfe","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ejim.2019.03.014_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1172\/JCI112785","article-title":"Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine","volume":"79","author":"Jensen","year":"1987","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ejim.2019.03.014_bb0195","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2337\/dc15-2732","article-title":"Bariatric surgery in obese patients with type 1 diabetes","volume":"39","author":"Kirwan","year":"2016","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ejim.2019.03.014_bb0200","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1007\/s00464-016-4901-2","article-title":"Outcome of bariatric surgery in patients with type 1 diabetes mellitus: our experience and review of the literature","volume":"30","author":"Rottenstreich","year":"2016","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.ejim.2019.03.014_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11695-018-3548-6","article-title":"Normal blood glucose and high blood ketones in a critically unwell patient with T1DM post-bariatric surgery: a case of euglycemic diabetic ketoacidosis","volume":"29","author":"Dowsett","year":"2019","journal-title":"Obes Surg"},{"issue":"2","key":"10.1016\/j.ejim.2019.03.014_bb0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1213\/XAA.0000000000000734","article-title":"When guidelines fail: euglycemic diabetic ketoacidosis after bariatric surgery in a patient taking a sodium-glucose cotransporter-2 inhibitor: a case report","volume":"11","author":"Lane","year":"2018","journal-title":"A A Pract"},{"key":"10.1016\/j.ejim.2019.03.014_bb0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.diabres.2003.12.004","article-title":"Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL)","volume":"65","author":"Tomihira","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.ejim.2019.03.014_bb0220","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/301790","article-title":"Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI","volume":"62","author":"Burwinkel","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.ejim.2019.03.014_bb0225","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/hmg\/7.5.865","article-title":"Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI","volume":"7","author":"Chang","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejim.2019.03.014_bb0230","first-page":"e88","article-title":"Euglycemic diabetic ketoacidosis with acute pancreatitis in a patient not known to have diabetes","volume":"1","author":"Prater","year":"2015","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.ejim.2019.03.014_bb0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/1947-2714.157490","article-title":"Euglycemic diabetic ketoacidosis, a misleading presentation of diabetic ketoacidosis","volume":"7","author":"Thawabi","year":"2015","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.ejim.2019.03.014_bb0240","article-title":"Euglycemic diabetic ketoacidosis in a patient with cocaine intoxication","author":"Abu-Abed Abdin","year":"2016","journal-title":"Case Rep Crit Care"},{"issue":"5","key":"10.1016\/j.ejim.2019.03.014_bb0245","first-page":"62","article-title":"Euglycemic diabetic ketoacidosis due to gastroparesis, a local experience","volume":"112","author":"Legaspi","year":"2015","journal-title":"J Ark Med Soc"},{"issue":"4","key":"10.1016\/j.ejim.2019.03.014_bb0250","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2337\/diacare.10.4.540","article-title":"Euglycemic diabetic ketoacidosis in Duchenne's muscular dystrophy","volume":"10","author":"Braithwaite","year":"1987","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ejim.2019.03.014_bb0255","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.diabres.2010.12.015","article-title":"True euglycemic diabetic ketoacidosis in a person with type 2 diabetes and Duchenne muscular dystrophy","volume":"92","author":"Lee","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ejim.2019.03.014_bb0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00569937","article-title":"Euglycaemic diabetic ketoacidosis: does it exist?","volume":"30","author":"Jenkins","year":"1993","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ejim.2019.03.014_bb0265","doi-asserted-by":"crossref","first-page":"557","DOI":"10.12968\/hosp.2003.64.9.2252","article-title":"Euglycaemic diabetic ketoacidosis","volume":"64","author":"Davies","year":"2003","journal-title":"Hosp Med"},{"key":"10.1016\/j.ejim.2019.03.014_bb0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ams2.13","article-title":"Alcoholic ketoacidosis that developed with a hypoglycemic attack after eating a high-fat meal","author":"Suzuki","year":"2014","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.ejim.2019.03.014_bb0275","article-title":"Severe ketoacidosis associated with canagliflozin (Invokana): a safety concern","author":"Gelaye","year":"2016","journal-title":"Case Rep Crit Care"},{"key":"10.1016\/j.ejim.2019.03.014_bb0280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/pdi.329","article-title":"Euglycaemic diabetic ketoacidosis","volume":"19","author":"McNulty","year":"2002","journal-title":"Pract Diabet Int"},{"key":"10.1016\/j.ejim.2019.03.014_bb0285","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1464-5491.2001.00558.x","article-title":"A case of euglycaemic diabetic ketoacidosis in pregnancy","volume":"18","author":"Franke","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.ejim.2019.03.014_bb0290","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/2230-8210.152793","article-title":"Sodium-glucose cotransporter-2 inhibition and the insulin: glucagon ratio: unexplored dimensions","volume":"19","author":"Kalra","year":"2015","journal-title":"Indian J Endocrinol Metab"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620519301037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620519301037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:29:06Z","timestamp":1760606946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620519301037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":58,"alternative-id":["S0953620519301037"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2019.03.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Euglycemic diabetic ketoacidosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2019.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}